pegylated exenatide (NLY01-PD) / D&D Pharmatech  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
pegylated exenatide (NLY01-PD) / D&D Pharmatech
NCT04154072: A Clinical Study of NLY01 in Patient's With Early Parkinson's Disease

Active, not recruiting
2
255
Canada, US
NLY01, Vehicle
Neuraly, Inc.
Parkinson Disease
03/23
03/23

Download Options